Lilly/Icos Will Launch Cialis DTC Ads Once Doctors Are “Fully Educated”

Patient preference will be one theme of professional promotions for Lilly/Icos' erectile dysfunction therapy Cialis, Icos CEO Paul Clark indicated Jan. 13 at the J.P. Morgan health care conference in San Francisco

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet